Jonathan Brajtbord

Mount Sinai Medical Center

Papers

11

Total Citations

329

H-Index

8

About

Jonathan Brajtbord is a urologic surgeon and researcher whose work has centered on improving outcomes for men with prostate cancer, particularly through the refinement of robot-assisted laparoscopic prostatectomy (RALP). His major contributions include demonstrating that nerve-sparing techniques can be safely applied even in preoperatively high-risk patients, and that high body mass index does not compromise surgical outcomes—findings that have helped broaden the eligibility for minimally invasive surgery. Brajtbord also critically evaluated imaging practices, showing that unnecessary staging scans for low-risk prostate cancer are common (83 citations) and that endorectal MRI has limited ability to predict pT3 disease (47 citations), thereby advocating for more judicious resource use. His research on surgeon experience and technical modifications (61 citations) has informed best practices in robotic surgery. Additionally, he pioneered the use of validated online questionnaires to monitor quality-of-life outcomes after prostatectomy. With over 300 cumulative citations, Brajtbord’s work has directly influenced clinical guidelines and surgical decision-making, making him a key voice in the evidence-based evolution of prostate cancer care.

Research Focus

Key Achievements

8
H-Index
11
Papers
329
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Unnecessary Imaging for the Staging of Low-risk Prostate Cancer Is Common
83 citations · 2010
📈 Most Prolific Year: 2010 (7 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Mount Sinai Medical Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago